A stochastically curtailed single-arm phase II trial design for binary outcomes

Phase II clinical trials are a critical aspect of the drug development process. With drug development costs ever increasing, novel designs that can improve the efficiency of phase II trials are extremely valuable. Phase II clinical trials for cancer treatments often measure a binary outcome. The fin...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Martin, Grayling, Michael J., Mander, Adrian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614398/
https://www.ncbi.nlm.nih.gov/pubmed/35077268
http://dx.doi.org/10.1080/10543406.2021.2009498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614398/
https://www.ncbi.nlm.nih.gov/pubmed/35077268
http://dx.doi.org/10.1080/10543406.2021.2009498

Ejemplares similares